Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.

Bugatti, Serena; De Stefano, Ludovico; Bobbio-Pallavicini, Francesca; Montecucco, Carlomaurizio

Bugatti, Serena; De Stefano, Ludovico; Bobbio-Pallavicini, Francesca; Montecucco, Carlomaurizio.

Bugatti S; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy serena.bugatti@unipv.it.
De Stefano L; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
Bobbio-Pallavicini F; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Montecucco C; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.

RMD Open ; 6(3)2020 10.

Article in English | MEDLINE | ID: covidwho-1388535

Subject(s)

Antirheumatic Agents/therapeutic use; Coronavirus Infections/prevention & control; Hydroxychloroquine/therapeutic use; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Rheumatologists; Antirheumatic Agents/pharmacology; Betacoronavirus/drug effects; COVID-19; Humans; Hydroxychloroquine/pharmacology; SARS-CoV-2

Keywords

Arthritis; Hydroxychloroquine; Lupus Erythematosus; Rheumatoid; Systemic

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Antirheumatic Agents / Pandemics / Rheumatologists / Hydroxychloroquine Limits: Humans Language: English Year: 2020 Document Type: Article Affiliation country: RMDOPEN-2020-001323

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google